KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Opko Health (OPK) Shares Outstanding (2016 - 2026)

Opko Health filings provide 17 years of Shares Outstanding readings, the most recent being $784.9 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 11.9% to $784.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $784.9 million, a 11.9% increase, with the full-year FY2025 number at $789.9 million, up 12.63% from a year prior.
  • Shares Outstanding hit $784.9 million in Q1 2026 for Opko Health, down from $789.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $809.6 million in Q2 2025 to a low of -$8.7 million in Q2 2022.
  • Median Shares Outstanding over the past 5 years was $781.3 million (2022), compared with a mean of $713.1 million.
  • Biggest five-year swings in Shares Outstanding: crashed 101.29% in 2022 and later surged 8497.28% in 2024.
  • Opko Health's Shares Outstanding stood at $781.3 million in 2022, then rose by 0.08% to $781.9 million in 2023, then dropped by 10.31% to $701.4 million in 2024, then grew by 12.63% to $789.9 million in 2025, then fell by 0.64% to $784.9 million in 2026.
  • The last three reported values for Shares Outstanding were $784.9 million (Q1 2026), $789.9 million (Q4 2025), and $798.9 million (Q3 2025) per Business Quant data.